HIV vaccinology: 2021 update
- PMID: 34272086
- PMCID: PMC8463426
- DOI: 10.1016/j.smim.2021.101470
HIV vaccinology: 2021 update
Abstract
HIV is a virus that remains a major health concern and results in an infection that has no cure even after over 30 years since its discovery. As such, HIV vaccine discovery continues to be an area of intensive research. In this review, we summarize the most recent HIV vaccine efficacy trials, clinical trials initiated within the last 3 years, and discuss prominent improvements that have been made in prophylactic HIV vaccine designs.
Keywords: Broadly neutralizing antibodies; Human immunodeficiency virus; Review; Vaccine.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declarations of interest
None
References
-
- Global HIV & AIDS statistics — 2020 fact sheet | UNAIDS, (n.d.). https://www.unaids.org/en/resources/fact-sheet (accessedDecember 18, 2020).
-
- Siegrist C-A, Vaccine Immunology, in: Plotkin’s Vaccines, Elsevier, 2018: pp. 16–34.e7. 10.1016/b978-0-323-35761-6.00002-x. - DOI
-
- Seaman MS, Janes H, Hawkins N, Grandpre LE, Devoy C, Giri A, Coffey RT, Harris L, Wood B, Daniels MG, Bhattacharya T, Lapedes A, Polonis VR, McCutchan FE, Gilbert PB, Self SG, Korber BT, Montefiori DC, Mascola JR, Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies, J. Virol 84 (2010) 1439–1452. 10.1128/jvi.02108-09. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
